Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00742170 · ClinicalTrials.gov registry record · Phase 1
Transdermal Electroacupuncture for Opioid Detoxification
A Phase 1 study of Opioid Dependency, sponsored by Mclean Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT00742170 is a Phase 1 study of Opioid Dependency that has completed, run by Mclean Hospital. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00742170, a Phase 1 study of Opioid Dependency, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-blind, randomized clinical trial tests whether electroacupuncture, provided as an adjunctive treatment, improves outcomes among patients receiving inpatient opioid detoxification from opioids.
Conditions Studied
Interventions
- DEVICE Electroacupuncture
Study Locations (1)
Massachusetts
- McLean Hospital - Belmont
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00742170
The ClinicalTrials.gov registry entry for NCT00742170 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Dependency appearing as the primary indexed condition, and to 1 intervention - of which Electroacupuncture is the first listed.
NCT00742170 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00742170 about?
NCT00742170 is a clinical study titled "Transdermal Electroacupuncture for Opioid Detoxification". This single-blind, randomized clinical trial tests whether electroacupuncture, provided as an adjunctive treatment, improves outcomes among patients receiving inpatient opioid detoxification from opioids.
What is the current status of trial NCT00742170?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2007-08. Estimated completion is 2010-01.
What conditions does trial NCT00742170 study?
This clinical trial studies the following conditions: Opioid Dependency.
What interventions are being tested in trial NCT00742170?
The interventions under investigation include: Electroacupuncture (DEVICE).
Who is sponsoring clinical trial NCT00742170?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00742170 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Dependency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.